Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

CAMTEK LTD (CAMT) Balance Sheet

As of 2025-12-31 (20-F), CAMTEK LTD (CAMT) reported total assets of $1.3B, total liabilities of $642.8M and shareholders' equity of $617.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $177.8M.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

CAMTCAMTEK LTDFollow CAMT — free
Scientific & Technical Instruments · Technology
—
Price chart with a free account
Market cap
5.6B
Annual P/E
116.5
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2010
Dec 10
FY2011
Dec 11
FY2012
Dec 12
FY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Dec 25
Trend
Cash and equivalents0.010.020.020.020.020.030.020.040.050.040.110.240.150.120.130.180.18
Short-term investments————————————0.000.020.030.080.08
Receivables0.030.030.020.030.020.030.020.020.030.030.040.060.080.090.100.090.09
Inventory——0.010.020.020.030.020.020.030.020.040.060.070.090.110.110.11
Current assets0.070.080.070.070.080.100.090.090.120.150.260.520.560.550.620.900.90
Total assets0.100.100.100.090.100.120.110.110.140.170.290.580.680.790.891.261.26
Current liabilities0.030.030.030.020.030.040.030.030.040.030.060.090.090.100.120.110.11
Long-term debt——0.00——————————————
Total liabilities0.040.040.040.030.030.050.030.030.040.030.060.290.290.310.340.640.64
Shareholders' equity0.050.060.060.060.070.070.070.080.100.140.230.290.380.480.550.620.62

USD billions · SEC XBRL

CAMTEK LTD — questions

How much cash does CAMTEK LTD have?
$177.8M in cash and cash equivalents as of 2025-12-31.
What are CAMTEK LTD's total assets?
$1.3B as of 2025-12-31.
What is CAMTEK LTD's shareholders' equity?
$617.0M as of 2025-12-31.

Every figure on this page comes from CAMTEK LTD's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.